Table 1.
Patient characteristics and FDG-PET/CT imaging findings
Patient n° | Sex | Age | Comorbidities | Symptoms | Exposure | Imaging | Follow-up at 1 week | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
N° of affected lobes | CT features (GGO or consolidative opacities) | SUVmax | LN (Y/N) | LN (SUV max) | Other findings | Symptoms therapy | ||||||
1 | F | 45 | Colon cancer | None | Family | 5 | Consolidative opacities | 4.3 | Y | 4.5 | Left pelvic lesion | No symptoms Antibiotic therapy |
2 | M | 67 | Rectal cancer Diabetes | None | Not known | 3 | GGO | 4.3 | N | – | Osteolytic lesion of the ischiatic right bone | Fever Mild respiratory symptoms Antibiotic therapy |
3 | F | 44 | Submandibular salivary gland cancer | None | Not known | 2 | Consolidative opacities and GGO | 11.3 | Y | 3.7 | Left laterocervical adenopathies | No symptoms, No therapy Husband hospitalized for respiratory symptoms |
4 | F | 56 | Ovary carcinoma | None | Not known | 3 | GGO | 5.3 | Y | 3.0 | Left laterocervical inflammatory uptake | No Symptoms, No therapy |
5 | M | 70 | Squamous cell cancer and nodal metastases from CUP, prostate cancer | None | Not known | 4 | GGO | 4.9 | Y | 3.0 | Right laterocervical swelling | Fever mild respiratory symptoms Antibiotic therapy |
CUP, cancer of unknown primary; F, female; GGO, ground glass opacities; LN, lymph node uptake; M, male; SUVmax, maximum standardized uptake value